Acquisition of the Drug Encorafenib [75 Mg; Cap/Comp] for ULSCB
About This Opportunity
TranslatedThis tender pertains to the acquisition of the pharmaceutical product Encorafenib, specifically in the dosage of 75 mg, in capsule or compressed form, intended for the Unidade Local de Saúde do Centro de Beira (ULSCB). The procurement aims to ensure the availability of this essential medication for patients requiring treatment as per the clinical guidelines established by the health authority. Key requirements for bidders may include the provision of relevant certifications, compliance with regulatory standards for pharmaceutical products, and the ability to deliver the medication within specified timeframes. The tender emphasizes the importance of quality assurance and adherence to safety protocols in the handling and distribution of the drug. Interested parties are encouraged to submit their proposals, detailing their capacity to meet the outlined specifications and delivery schedules. The location of service delivery is within the jurisdiction of ULSCB, which serves a significant population in the region. This acquisition is part of a broader initiative to enhance healthcare services and ensure that patients have access to necessary treatments. Bidders should also be prepared to demonstrate their experience in supplying similar pharmaceutical products to healthcare institutions.
This is a supplies contract in the health and medical services, trade and industry and general supplies sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 42,877.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender seeks the procurement of Encorafenib, a medication available in 75 mg capsule form, specifically intended for use by the Unidade Local de Saúde do Cávado e do Ave (ULSCB) in Portugal. The procurement of pharmaceuticals like Encorafenib is a critical component of healthcare supply chains, ensuring that medical facilities have access to essential medications required for patient care.
As part of this tender process, the contracting authority is looking for qualified suppliers who can provide the medication in compliance with all applicable regulations and standards. Suppliers must demonstrate their ability to deliver the product in a timely manner, reflecting the urgency often associated with pharmaceutical supplies. Additionally, bidders should provide evidence of their capacity to meet quality assurance protocols, as the integrity of medicinal products is paramount in healthcare settings.
Typical requirements for this type of tender may include submission of relevant certifications, proof of good manufacturing practices (GMP), and adherence to the specific storage and transportation conditions needed to maintain the efficacy of the medication. Suppliers may also be expected to outline their distribution capabilities and any after-sales support they can offer to the ULSCB.
This procurement process is part of a broader initiative to enhance the quality of healthcare services in Portugal, ensuring that public health institutions have reliable access to necessary treatments. Interested parties are encouraged to participate in this tender to contribute to the advancement of healthcare in the region.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 16, 2026. Last refreshed 8 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About UNIDADE LOCAL DE SAÚDE DE CASTELO BRANCO, E.P.E.
UNIDADE LOCAL DE SAÚDE DE CASTELO BRANCO, E.P.E. has issued 22 procurement notices on BidsFactory, including 0 currently open and 19 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 16, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to PIERRE FABRE MÉDICAMENT PORTUGAL, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by UNIDADE LOCAL DE SAÚDE DE CASTELO BRANCO, E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €42,877. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.